BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31941083)

  • 1. Glycine Cleavage System and cAMP Receptor Protein Co-Regulate CRISPR/
    Yang D; Wang Z; Ma J; Fu Q; Wu L; Wang H; Wang S; Yan Y; Sun J
    Viruses; 2020 Jan; 12(1):. PubMed ID: 31941083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cas3-stimulated runaway replication of modified ColE1 plasmids in Escherichia coli is temperature dependent.
    Radovčić M; Čulo A; Ivančić-Baće I
    FEMS Microbiol Lett; 2019 May; 366(9):. PubMed ID: 31095294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cas3 is a limiting factor for CRISPR-Cas immunity in Escherichia coli cells lacking H-NS.
    Majsec K; Bolt EL; Ivančić-Baće I
    BMC Microbiol; 2016 Mar; 16():28. PubMed ID: 26956996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the Type I-F CRISPR-Cas system by CRP-cAMP and GalM controls spacer acquisition and interference.
    Patterson AG; Chang JT; Taylor C; Fineran PC
    Nucleic Acids Res; 2015 Jul; 43(12):6038-48. PubMed ID: 26007654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cas3-Derived Target DNA Degradation Fragments Fuel Primed CRISPR Adaptation.
    Künne T; Kieper SN; Bannenberg JW; Vogel AI; Miellet WR; Klein M; Depken M; Suarez-Diez M; Brouns SJ
    Mol Cell; 2016 Sep; 63(5):852-64. PubMed ID: 27546790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repetitive DNA Reeling by the Cascade-Cas3 Complex in Nucleotide Unwinding Steps.
    Loeff L; Brouns SJJ; Joo C
    Mol Cell; 2018 May; 70(3):385-394.e3. PubMed ID: 29706536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CasA mediates Cas3-catalyzed target degradation during CRISPR RNA-guided interference.
    Hochstrasser ML; Taylor DW; Bhat P; Guegler CK; Sternberg SH; Nogales E; Doudna JA
    Proc Natl Acad Sci U S A; 2014 May; 111(18):6618-23. PubMed ID: 24748111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRP represses the CRISPR/Cas system in Escherichia coli: evidence that endogenous CRISPR spacers impede phage P1 replication.
    Yang CD; Chen YH; Huang HY; Huang HD; Tseng CP
    Mol Microbiol; 2014 Jun; 92(5):1072-91. PubMed ID: 24720807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disabling a Type I-E CRISPR-Cas Nuclease with a Bacteriophage-Encoded Anti-CRISPR Protein.
    Pawluk A; Shah M; Mejdani M; Calmettes C; Moraes TF; Davidson AR; Maxwell KL
    mBio; 2017 Dec; 8(6):. PubMed ID: 29233895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular insights into DNA interference by CRISPR-associated nuclease-helicase Cas3.
    Gong B; Shin M; Sun J; Jung CH; Bolt EL; van der Oost J; Kim JS
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16359-64. PubMed ID: 25368186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clustered Regularly Interspaced Short Palindromic Repeat-Dependent, Biofilm-Specific Death of Pseudomonas aeruginosa Mediated by Increased Expression of Phage-Related Genes.
    Heussler GE; Cady KC; Koeppen K; Bhuju S; Stanton BA; O'Toole GA
    mBio; 2015 May; 6(3):e00129-15. PubMed ID: 25968642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Easy regulation of metabolic flux in Escherichia coli using an endogenous type I-E CRISPR-Cas system.
    Chang Y; Su T; Qi Q; Liang Q
    Microb Cell Fact; 2016 Nov; 15(1):195. PubMed ID: 27842593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GcvR interacts with GcvA to inhibit activation of the Escherichia coli glycine cleavage operon.
    Ghrist AC; Heil G; Stauffer GV
    Microbiology (Reading); 2001 Aug; 147(Pt 8):2215-2221. PubMed ID: 11495998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role for the leucine-responsive regulatory protein (Lrp) as a structural protein in regulating the Escherichia coli gcvTHP operon.
    Stauffer LT; Stauffer GV
    Microbiology (Reading); 1999 Mar; 145 ( Pt 3)():569-576. PubMed ID: 10217490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A compact Cascade-Cas3 system for targeted genome engineering.
    Csörgő B; León LM; Chau-Ly IJ; Vasquez-Rifo A; Berry JD; Mahendra C; Crawford ED; Lewis JD; Bondy-Denomy J
    Nat Methods; 2020 Dec; 17(12):1183-1190. PubMed ID: 33077967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Tryptophan 'Gate' in the CRISPR-Cas3 Nuclease Controls ssDNA Entry into the Nuclease Site, That When Removed Results in Nuclease Hyperactivity.
    He L; Matošević ZJ; Mitić D; Markulin D; Killelea T; Matković M; Bertoša B; Ivančić-Baće I; Bolt EL
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicase dissociation and annealing of RNA-DNA hybrids by Escherichia coli Cas3 protein.
    Howard JA; Delmas S; Ivančić-Baće I; Bolt EL
    Biochem J; 2011 Oct; 439(1):85-95. PubMed ID: 21699496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct Subcellular Localization of a Type I CRISPR Complex and the Cas3 Nuclease in Bacteria.
    Govindarajan S; Borges A; Karambelkar S; Bondy-Denomy J
    J Bacteriol; 2022 May; 204(5):e0010522. PubMed ID: 35389256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Target DNA recognition and cleavage by a reconstituted Type I-G CRISPR-Cas immune effector complex.
    Majumdar S; Ligon M; Skinner WC; Terns RM; Terns MP
    Extremophiles; 2017 Jan; 21(1):95-107. PubMed ID: 27582008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple mechanisms for CRISPR-Cas inhibition by anti-CRISPR proteins.
    Bondy-Denomy J; Garcia B; Strum S; Du M; Rollins MF; Hidalgo-Reyes Y; Wiedenheft B; Maxwell KL; Davidson AR
    Nature; 2015 Oct; 526(7571):136-9. PubMed ID: 26416740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.